Detalhe da pesquisa
1.
Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis.
Toxicol Appl Pharmacol
; 368: 49-54, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30794826
2.
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.
Liver Int
; 37(7): 1074-1081, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097795
3.
Latent carcinogenicity of early-life exposure to dichloroacetic acid in mice.
Carcinogenesis
; 36(7): 782-91, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913432
4.
Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
Drug Metab Dispos
; 43(2): 266-72, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488932
5.
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.
Amino Acids
; 47(3): 603-15, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534430
6.
Synergistic interaction between genetics and disease on pravastatin disposition.
J Hepatol
; 61(1): 139-47, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24613363
7.
Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression.
J Pharmacol Exp Ther
; 348(3): 452-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403518
8.
Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models.
Drug Metab Dispos
; 42(4): 586-95, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384915
9.
Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.
Dig Dis Sci
; 59(2): 365-74, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24048683
10.
Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.
J Appl Toxicol
; 34(6): 726-32, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217942
11.
Discovery of Hepatitis B Virus Surface Antigen Suppressor GS-8873.
ACS Med Chem Lett
; 15(4): 546-554, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38628802
12.
Differential regulation of hepatic organic cation transporter 1, organic anion-transporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production.
J Pharmacol Exp Ther
; 347(1): 136-44, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929842
13.
Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.
Drug Metab Dispos
; 41(3): 554-61, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223517
14.
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.
Toxicol Appl Pharmacol
; 268(2): 132-40, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391614
15.
Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
Drug Metab Dispos
; 40(9): 1817-24, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22699396
16.
Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies.
Toxicol Sci
; 186(2): 298-308, 2022 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134235
17.
Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.
Drug Metab Dispos
; 39(10): 1954-60, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21737566
18.
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.
Drug Metab Dispos
; 38(12): 2293-301, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20805291
19.
Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts.
Proteome Sci
; 8: 32, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546627
20.
Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model.
Obesity (Silver Spring)
; 25(6): 1069-1076, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28452429